CHINARES PHARMA

03320

----

Current ValuationThe current P/E ratio is 5.64, below the reasonable range, cheaper than 99.54% of the time in the past 5 years, and the industry ranks 3/52, the industry Median 6.62.

5.64xP/E

Stock priceHK$4.30Earnings per shareHK$0.76

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

Industry median 6.62x

010203040

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

Industry median 6.62x

0x20x40x60x80x100x

P/E ratio
Name/Symbol
03320HKCHINARES PHARMA	5.64x	7.23%	HK$26.98B
01681HKCONSUN PHARMA	9.07x	20.93%	HK$12.27B
02186HKLUYE PHARMA	9.12x	46.95%	HK$7.31B
02877HKSHINEWAY PHARM	6.53x	16.75%	HK$6.05B
02633HKJACOBSON PHARMA	6.37x	1.99%	HK$1.92B
02348HKDAWNRAYS PHARMA	5.46x	--	HK$1.46B
02161HKJBM HEALTHCARE	6.62x	6.78%	HK$1.33B
08049HKJILIN CHANGLONG	5.17x	--	HK$1.30B
00239HKPAK FAH YEOW	7.72x	--	HK$763.52M
00950HKLEE'S PHARM	5.75x	--	HK$688.94M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.